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CObjectives: To measure the utility of patients with ureteral stones un-
der variousmedical regimes and to identify significant factors affecting
utility for various health states. Methods: A cross-sectional survey
as conducted to measure the utility of 89 patients on each health
tate related to the clinical management of ureteral stones. Health
tateswith respect to intervention and treatmentmodalitieswere clas-
ified into the acute phase (includingmedication, extracorporeal shock
ave lithotripsy, ureterorenoscopic lithotripsy, and surgery) and the
hronic phase (no specific intervention, lifestyle modification, mainte-
ance with surveillance, and continued medication). Utility was mea-
ured by using the modified standard gamble. Demographic data and
elevant history of treatment modalities and interventions for ureteral
tones were collected by using a questionnaire. Results: Utility scores
f health states in the acute phase (ranging from0.914 [surgery] to 0.967
extracorporeal shock wave lithotripsy]) were lower than those in the
hronic phase (ranging from 0.955 [maintenance with surveillance] to
.974 [lifestyle modification]). Utility for surgery was lower than for
onsurgical methods. Utilities for the two lithotripsy modalities were O
e no
of E
ipei 1
al So
doi:10.1016/j.vhri.2012.03.004lose to that for medication. The utility figures for health states in
he chronic phase were the highest for lifestyle modification, but the
ifferences across health states were trivial. Sex, history of uretero-
enoscopic lithotripsy, education level, and employment were sig-
ificant covariates in the final multiple linear regression model.
onclusions: A modified standard gamble chained method was ap-
lied to measure the utility for health states in relation to the clinical
anagement of ureteral stones. Patients preferred nonsurgical treat-
ent over surgical treatment and hemodialysis regardless of health
tates. We also found that sex, a history of ureterorenoscopic litho-
ripsy, education level, and employment affected utility for health
tates related to clinical management. Our findings provide an insight
nto patient preference for the choice of treatment of ureteral stones.
eywords: extracorporeal shock wave lithotripsy, standard gamble
pproach, ureteral stones, ureterorenoscopic lithotripsy, utility.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Clinical management of ureteral stone, an illness with a high like-
lihood of recurrence [1], was dominated by surgery before the ad-
ent of extracorporeal shock wave lithotripsy (ESWL) and uretero-
enoscopic lithotripsy (URSL), which have been adopted as
rimary treatment modalities for removing ureteral stones [2].
These two treatments together with the high recurrence rate of
ureteral stones leave patients in a dilemma regarding whether to
undergo these treatments, particularly for prophylactic purposes
for treating small silent renal stones. Althoughpatient utility plays
a crucial role in selecting the treatment plan for ureteral stones,
few studies have been conducted to address this issue. To the best
of our knowledge, only one pervious study measured patient util-
ity in the treatment of upper urinary tract calculi [3]. However,
several concerns have been raised in this study. The classification
Conflicts of interest: The authors have indicated that they hav
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National Taiwan University, Room 533, No. 17, Hsuchow Road, Ta
E-mail: chenlin@ntu.edu.tw.
2212-1099/$36.00 – see front matter Copyright © 2012, Internation
Published by Elsevier Inc.for health states corresponding to each utilitymeasurement is too
broad to reflect the complex of heath states involved in state-of-
the-art clinical scenario of treating ureteral stones. Factors affect-
ing patient preference have not been fully investigated. Because
the patient preference may vary with time, place, and ethnic
group, it is worthwhile to measure patient preference over the
choice of treatment modality with refined classifications to adapt
the updated treatment modalities and preventive strategies of
ureteral stone and identify its associated factors.
Among three common direct eliciting methods—standard
gamble [SG], time trade-off method, and visual analogue scale—
for measuring the utility [4–12], each has strength and weakness
in the aspects of practicality, reliability, and validity [4–14]. We
prefer choice-based techniques (SGand time trade-off) to choice-less
methods such as visual analogue scale [8,15]. Of the two choice-
based methods, although the impact of three bias (probability
weighting, loss aversion, and scale comparability) on utility curva-
conflicts of interest with regard to the content of this article.
pidemiology and Prevention Medicine, College of Public Health,
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lected the SG method as our method for measuring utility partly
because it is not only tailored for the reflection of decision making
under uncertainty of clinical management of ureteral stone in the
light of the axiom of expected utility theory [17] but also dispenses
with the assumption of linear utility for duration used in the time
trade-off method that is a riskless property [13,15].
Therefore, this study applied the modified SG approach to
measure the utility of patients with ureteral stones under various
medical treatment regimes. Significant factors affecting the utility
of different health states included in the management were also
identified to estimate patient utility.
Methods
Study subjects
A cross-sectional survey was conducted in 267 patients aged 20 to
65 years from the Department of Urology of Min-Sheng General
Hospital, Tayouan, Taiwan, who soughtmedical treatment for dif-
ferent types of ureteral stones between March and May 2007. Of
the 267, 118 were outpatients who did not require further therapy,
96 were being treated with ESWL, and 53 were being treated with
URSL. Fifty-two patients were randomly selected to represent 118
outpatients. All patients treatedwith ESWL or URSLwere enrolled.
Finally, a total of 201 outpatients were invited to attend this study.
We used a questionnaire to collect demographic data, including
age, sex, education level, employment, and history of ureteral
stone treatment. The medical terms, particularly for surgical
treatment, contained in the scenario were explained to patients
with explicit Chinese language by the interviewer.
Health state of patients with ureteral stones
Utility measured in our study was for patients undergoing differ-
ent treatments for acute and chronic ureteral stones. Treatments
in the acute phase were subdivided into four categories: medica-
tion, ESWL, URSL, and surgery. Those in the chronic phase were
classified as no specific intervention, lifestyle modification, main-
ESWL 
URSL 
Surgery 
Medication
States being 
measured 
As ranked by 
the subject 
Hemodialysis
Obtain the relative utility value 
using the standard gamble method
Healthy 
Dead 
U1–2
U2–3
U3–4
U4–5
U5
2. Medication
1. ESWL
3. URSL 
4. Surgery 
Fig. 1 – Flowchart for ranking and measuring the relative
utility between reference states. ESWL, extracorporeal
shock wave lithotripsy; URSL, ureterorenoscopic
lithotripsy.tenance with surveillance, and continued medication.The modified SG method
Step 1: Measuring the absolute utility for hemodialysis
Becausehemodialysiswas themost serious complication in patients
with ureteral stones in this study and is common in Taiwan, we
assume it is theworst state for thesubject alivebutbetter thandeath.
We used the SGmethod to estimate the absolute utility for hemodi-
alysis, defined as U5 (Fig. 1), by using healthy and dead as reference
states with two extreme states of utility as “1” and “0,” respectively.
To measure utility for a chronic health state, say state i, a scenario
as described as follows: “A male diagnosed with end-stage renal
isease has been treatedwith conventional treatment-hemodialysis
hree times per week-for a long time. A new treatment is available
hat may render him completely healthy with probability p, but he
lso runs the risk of dying if the treatment fails.”Whether he accepts
new treatment depends onhis preference over the utility of under-
oing this new treatment determined by the degree of chance that
akes him consider the new treatment as indifferent to the conven-
ionalmethod, oneaccepting thenew treatmentwithprobability pof
ttaining the best state (healthy) andwith failure probability (1 – p) of
ecoming worse, or rejecting the new treatment and receiving the
onventional treatment given the current state i being measured. We
sedan iterativebiddingprocess to identifyp,which isutility forhemo-
ialysis according to the expected utility theory [17], which indicates
hat the utility for state i for the above scenario is equivalent to
i pUb  1 pUw
where Ub  1 and Uw represent the utility values of the best
healthy  1) and the worst states (dead  0), respectively.
Step 2: Ranking the states in the same phase
In our case, healthy status was always regarded as the best refer-
ence state (score 1), whereas the worse state depended on each
subject’s ranking sequence. We used the four states in the acute
phase for ureteral stone management as an example (see Fig. 1).
100% Healthy 
0% HD
10% Healthy 
90% HD
5% Healthy 
95% HD
90% Healthy 
10% HD
0% Healthy 
100% HD
2.5% Healthy 
97.5% HD
No  *  Yes 
No  *  Yes
No  *  Yes 
No  *  Yes95% Healthy 
5% HD
20% Healthy 
80% HDNo  *  Yes 
97.5% Healthy 
2.5% HD
92.5% Healthy 
7.5% HD
No  *  Yes
15% Healthy 
85% HD
7.5% Healthy 
92.5% HD
80% Healthy 
20% HD
No  *  Yes
No  *  Yes 
17.5% Healthy 
82.5% HD
12.5% Healthy 
87.5% HD
No  *  Yes
Start 
With probability p of being healthy and probability of (1–p) 
of becoming the worst state (e.g., Hemodialysis (HD) 
No/Reject Yes/Accept 
* Indifferent point 
Fig. 2 – Flowchart of the standard gamble method for
measuring utility.
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phase were ranked by each subject.
Step 3: Measuring relative utility
Figure 2 shows the process used to obtain the indifferent point
etween the target state and the reference states, which was
imilar to the method used in the previous study [18]. For ex-
ample, say we want to measure a man’s utility for surgery,
which he ranks as fourth among the four states in the acute
phase, as shown in Figure 1.
In addition to death status, which is assumed as the worst
utility here, the relative utility value of rank 4 was measured be-
tween the worst state (hemodialysis) and the best state (healthy)
by creating the following scenario: “Would you choose a surgery
that could render you be completely healthywith probability p, but
lead to hemodialysis with probability (1 – p) if the surgery fails?”
Following the conventional SG method, we estimated the proba-
bility of the indifferent point, that is, utility, between the two op-
tions by approaching it from both the bottom side where p  0%
nd the top side where p  100% following the iterative bidding
ethod using 2.5% as an incremental unit similar to the procedure
sed by Bosch and Hunink [18].
The same procedurewas repeated to attach a probability of the
ndifferent point for estimating the relative utility for U4–5. Simi-
larly, we measured the utility for other states with ranks 1 to 3.
This procedure was also applied to measure utilities for the treat-
ment of the chronic state.
Step 4: Using the chained method to convert relative utility into
absolute utility
The chained method [19–21] was further adopted to convert rela-
ive utility into absolute utility as follows:
4U5 (1U5)U45
U3U4 (1U4)U34
U2U3 (1U3)U23
U1U2 (1U2)U12
Suppose his or her U5, U4-5, and U3-4 were 0.5, 0.9, and 0.775, re-
spectively. We can convert the relative utility to absolute utility of
URSL, denoted as U3.
3  U4 (1U4)U34
 [U5 (1U5)U45] 1 [U5 (1U5)U45]U34
 0.5 (1 0.5) 0.9 [1 (0.5 (1 0.5) 0.9)] 0.775
 0.98875
Other values were also converted in a similar manner.
Statistical analysis
Because the majority of absolute utilities of ureteral stones for
different treatment conditions exceeded 0.9, we converted the
range of utilities by using complementary log–log transforma-
tion for the purpose of conducting regression analysis [22]. The
use of such transformed utility Ui* (e.g., –ln[–ln(Ui)]), where Ui is
he original absolute utility score of state i is pursuant to the
principle of generalized linear model [23] when the expected
value of outcome such as utility is close to 1 [22]. Then, a mul-
tiple linear regressionmodel was applied to estimate the effects
of relevant covariates on the transformed utility. We estimated
the expected individual utility score E(U) as follows:E(U) exp{exp[( CX)]}where  is the intercept, X is the vector of a set of covariates that
were statistically significant in the multiple linear regression
model, and C is the corresponding regression coefficient for X. We
elected the covariates included in the multiple regressions with
he “enter”method. The entry for themodel for the covariateswas
et at p value less than 0.1, and the statistically significant level
was set at 0.05. Adjusted R2 values were also reported to estimate
he proportion of variance explained by the covariates considered
n themodel with adjustment for the number of parameters given
egree of freedom. Statistical analysis was implemented by using
AS 9.1 (SAS Institute, Inc., Cary, NC).
Results
We completed the utility measurement based on 89 patients.
The response rate was 44% (89 of 201). Information on the char-
acteristics of 56% dropout subjects was not available, but we
believe the reasons for dropout may not be related to our utility
measurement because patients who sought medical care in the
same hospital in Taiwan would have similar background such
as socioeconomic status. The average interview time was
around 20 minutes. The mean age was 43  10.4 years. The
proportion of men was threefold than that of women. Around
68% of the subjects had education level at senior high school or
above (Table 1).
Table 2 shows the mean value and SD for the patients with
ureteral stones. Utility for hemodialysis was 0.399  0.343. Util-
ity for surgery was the lowest one after hemodialysis. Utility of
health states in the acute phase was lower than of those in the
chronic phase. Utilities in the acute phase ranged from 0.914
(surgery) to 0.967 (ESWL). Those in the chronic phase ranged
from 0.955 (maintenance with surveillance) to 0.974 (lifestyle
modification). Utility for surgery was lower than those for non-
surgical methods. Utilities for the two lithotripsy modalities
were was close to that for medication. The utility figure for
health states in the chronic phase was the highest for lifestyle
Table 1 – Characteristic of the participants (n = 89).
Variable Mean  SD or
proportion
Age (y) 43  10.4
Sex, n (%)
Man 67 (75)
Woman 22 (25)
Education level, n (%)
Primary school 14 (16)
Junior high school 14 (16)
Senior high school 28 (31)
Undergraduate 30 (34)
Graduate 3 (3)
Working status, n (%)
None 17 (19)
Part-time 5 (6)
Full-time 67 (75)
History of ESWL, n (%)
No 13 (15)
Yes 76 (85)
History of URSL, n (%)
No 29 (33)
Yes 50 (56)
ESWL, extracorporeal shock wave lithotripsy; URSL, ureteroreno-
scopic lithotripsy.
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90 V A L U E I N H E A L T H R E G I O N A L I S S U E S 1 ( 2 0 1 2 ) 8 7 – 9 2modification, but the differences across health states were
trivial.
Table 3 shows the results analyzed with the multiple linear
regression model by each state. Sex and history of URSL were
two major significant covariates in the final model, whereas
education and employment may also make contributions but
depend on the health states of ureteral stone management.
Note that age, history of ESWL, and history of surgery were not
statistically associated with any health state. None of the cova-
riate was statistically significant in the regression analysis for
no specific intervention (data not shown). Regardless of health
states, utility of women was consistently lower than that of
men. Those who had previous URSL had higher utility than
those who had not. The significant associations were found not
only for health states in the acute phase but also for those in the
chronic phase. Those with a lower education level had lower
utility than did those with a high education level, but the sta-
tistically significant associations were noted only for the two
health states of medication and URSL in the acute phase. Those
who were employed had a higher utility than those who were
unemployed, but the significant association was noted only for
medication in the acute phase. The bottom panel of Table 3
shows the results of adjusted R2. The values in the acute phase
were higher than those in the chronic phase. The highest was
URSL (14.24%) followed by medication (13.68%) and ESWL
(10.33%). The adjusted R2 values were lower than 10% for sur-
gery and other health states in the chronic phase (Table 3).
Table 4 shows the results of regression analysis by combing
all nonsurgical methods as one group in the acute phase. The
utility for surgery was statistically significantly lower than that
for nonsurgical treatment in the acute phase after adjusting for
other covariates. Again, only significant covariates (including
sex, previous URSL, education level, and employment) identi-
fied in univariate analysis were included in the final model.
Discussion
Because patient preference plays a crucial role in selecting the
treatment plan for the clinical management of ureteral stones,
this study used a modified SG method following the axioms of
Neumann–Morgenstern utility theory [17], where all treatments
during each phase in this study were ranked by patients and the
indifferent point between the two anchors was identified to
measure the utility for different treatments and interventions.
We also identified demographic features and relevant factors
responsible for utility.
In contrast to the previous study [3] addressing the measure-
Table 2 – Distribution of the utility score (n = 89).
Phase and state Mean  SD
Treatment in the acute phase
Medication 0.963  0.108
ESWL 0.967  0.107
URSL 0.953  0.124
Surgery 0.914  0.159
Intervention in the chronic phase
No specific intervention 0.959  0.090
Lifestyle modification 0.974  0.076
Maintenance with surveillance 0.971  0.079
Continued medication 0.955  0.088
Hemodialysis 0.399  0.343
ESWL, extracorporeal shock wave lithotripsy; URSL, ureteroreno-
scopic lithotripsy.ment of patient utility for choosing different treatment modal-T V In S U E E A N E *
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their study are several-fold. First, the worst group except death
used in their study was based on patients with nephrectomy,
whereas the corresponding group used in our study was based
on patients with hemodialysis because nephrectomy is rare in
Taiwan. Second, health states considered in their study for
measuring utility were different from ours. We separated treat-
ment into acute and chronic phases. For example, the acute
phase in our study was given a new state. As far as the chronic
phase is concerned, they considered only medication but we
took into account other methods such as lifestyle modification,
no specific intervention, and surveillance. Third, we used the
chained method to convert relative utility into absolute utility.
The reason is that our classification of health states included
temporary and nonrisky health states, although our chained
method is more complicated than the previously used chained
method [19–21].
Compared with the previous study [3], utility for surgery was
lower than that for nonsurgicalmethod as seen in both studies. By
looking at absolute figures with similar health states, utility for
surgery in their study was 0.93 (0.01–0.99), which was slightly
higher than that obtained in our study, 0.91(0.24–0.99). Utility for
long-termmedication in their studywas slightly lower than that in
our study (0.94  0.15 vs. 0.96  0.088). However, the SD of ours is
maller than theirs.
Because patient utility varies from individual to individual,
dentifying factors affecting patient utility for health states re-
ated to the choice of treatments is worthy of being investigated
nd has been barely addressed. Factors affecting utility identi-
ed in our study included sex, history of URSL, and employ-
ent. Those patients with history of URSL had higher utility in
hose conditions (including ESWL, URSL, lifestyle modification,
aintenance with surveillance, continuedmedication) than did
hose without a history of URSL whereas it did not affect utility
or surgery and the irreversible renal failure condition such as
emodialysis. These findings imply that patients after experi-
ncing the effective URSL were optimistic toward all noninva-
ive treatment or preventive strategy. The reason of having
ower utility for people with high education level in URSL and
edication may be due to a higher expectation toward the ef-
ectiveness of two treatment modalities in relieving the pain
aused by ureteral stones compared with those with low edu-
ation level. The finding that employment was associated only
ith medication may be explained by the concern over time
ost that encourages them to take medication rather than other
ime-consuming treatments. However, the true causes should
e validated in the future. In addition, the regression coeffi-
Table 4 – The difference of utility score between surgical
and nonsurgical in the acute phase after adjusting for
other covariates.
Variable Estimate SD P
Intercept 8.157 0.879 0.0001
Surgical vs. nonsurgical 3.187 0.389 0.0001
Sex (woman vs. man) 2.204 0.411 0.0001
Education (senior high school
and above vs. under)
0.502 0.163 0.0022
Employment (employed vs.
unemployed)
2.252 0.737 0.0024
ESWL experience (yes vs. no) 1.029 0.486 0.0348
URSL experience (yes vs. no) 1.347 0.369 0.0003
Adjusted R2  0.258.
ESWL, extracorporeal shock wave lithotripsy; URSL, ureteroreno-
scopic lithotripsy.ients of statistically significant items presented in Table 3ould give an individual patient expected utility using the
quation. For example, the expected utility score of ESWL for a
emale with a previous URSL equals exp{exp[(7.450 2.077
female  1)  2.153  (history of previous URSL  1)]}  0.9995
and that of continued medication equals exp{exp[(4.513 
.067  (female)  1.055  (history of previous URSL)]}  0.9890.
ndividuals with different combinations of covariates can be
stimated in the same way. Predicating an individual utility
ith different characteristics may make a contribution to con-
idering individual-tailored decision making on treatment mo-
ality and preventive strategies of ureteral stones in the future.
There are several concerns and limitations in our study. The
rst concern is that utility for treatment in the acute phase
anged from 0.914 (surgery) to 0.967 (ESWL). One reason for such
narrow range and higher utility may be that modified SG was
sed to measure preferences over quality of life resulting from
reatment rather than treatment regimen. Consequently, al-
hough different treatments are given to patients, quality of life
fter treatment tends to be similar and utilities are not much
ifferent. However, from the methodological viewpoint, this
ay also be related to the application of the modified SG
ethod that has been consistently reported to have an upward
ias resulting from probability weighting [13,15,16]. The second
imitation is a low response rate (44%). The major reason is that
he interview with modified SG procedure is time-consuming,
nd participants may refuse to participate. The third concern is
hat as the adjusted R2 is not very high, this suggests that utility
ay vary by other factors not measured in this study. Moreover,
lower adjusted R2 in the chronic phase compared with that in
he acute phase may suggest a further study to identify other
actors accounting for the utility of health states in the chronic
hase.
In conclusion, a modified SG chain method was applied to
easure the utility of health states in relation to the manage-
ent of ureteral stones. Patients tend to prefer nonsurgical
reatment over surgical treatment and hemodialysis. We also
ound that sex, a history of URSL, education level, and employ-
ent affected utility. Our findings provide an insight into pa-
ient preference for the choice of treatment for ureteral stones.
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